#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma stage II Alpha-1 antitrypsin deficiency Transplant rejection Endocrine ophthalmopathy NTRK gene fusion overexpression Kawasaki's disease Cutaneous T-cell lymphoma refractory Gastrointestinal neuroendocrine tumour Staphylococcal infection Juvenile chronic myelomonocytic leukaemia Familial hypertriglyceridaemia Neuropathic arthropathy Hyperoxaluria Chronic granulomatous disease Primary biliary cholangitis More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Basic Information Cholangitis sclerosing – Trials in Disease Myelodysplastic syndrome – Trials in Disease Toxic epidermal necrolysis – Basic Information Haemophilia B with anti factor IX – Basic Information Paroxysmal nocturnal haemoglobinuria Sarcoidosis Langerhans cell sarcoma – Diagnostics Lymphangiosarcoma – Treatment Rhabdomyosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Omo-103 Ixazomib Ly3819469 Sodium ICEF15 Raltegravir Aluminium Oxide, Hydrated Danicopan Terbinafine Ceftazidime Linsitinib Alnus Glutinosa Pollen BROLUCIZUMAB Aptamer-4Ft Carbetocin Voclosporin Naproxen Sodium Fostemsavir Doxycycline Botulinum Toxin Type A Siltuximab More therapies…

    Learn about Your Condition

    Alagille syndrome Type IIa hyperlipidaemia Onychomycosis Postoperative delirium Adrenocortical carcinoma Narcolepsy Adrenal insufficiency Adrenogenital syndrome CDKL5 deficiency disorder Colorectal cancer Malignant melanoma of eyelid Brain neoplasm Tumour thrombosis Pre-eclampsia Vulval cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Axitinib and Avelumab for Patients with Localized Renal Cell Carcinoma at Moderate to High Risk of Recurrence

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    • Avelumab
    The Netherlands

  • Study on Inhaled Levofloxacin for Treating Community-Acquired Pneumonia in Patients Without Systemic Antibiotics

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Levofloxacin
    Denmark

  • Study on Bevacizumab Dose Equivalence for Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer Using Bevacizumab, Olaparib, Carboplatin, and Paclitaxel

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant peritoneal neoplasm
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Olaparib
    Poland

  • Study on the Safety of LY3884961 for Patients with Type 1 Gaucher Disease

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 9 Expressing Codon-Optimized Human Gba Gene
    • Eculizumab
    • Methylprednisolone
    Germany Spain

  • Study on the Safety and Effectiveness of ApTOLL for Patients with ST Elevation Myocardial Infarction (STEMI)

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Myocardial infarction
    Investigated Drugs:
    • Aptamer-4Ft
    Spain

  • Study on the Safety and Effectiveness of TARA-002 for Adults with High-Grade Non-Muscle Invasive Bladder Cancer

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Bladder cancer stage 0 with cancer in situ
    • Bladder cancer stage I with cancer in situ
    Investigated Drugs:
    • Streptococcus Pyogenes, Group A, Type 3, Strain Su, Inactivated
    Romania Spain
Previous Page
1 … 879 880 881 882 883 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!